ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 166 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$373,000
-58.3%
27,500
-74.8%
0.00%
-50.0%
Q1 2019$894,000
+78.8%
109,199
+108.0%
0.00%
+100.0%
Q1 2018$500,000
-79.0%
52,500
-56.6%
0.00%
-83.3%
Q3 2017$2,382,000
+326.1%
121,089
+211.3%
0.01%
+200.0%
Q2 2017$559,000
+314.1%
38,900
+165.0%
0.00%
Q1 2017$135,00014,6780.00%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$13,027,0005.13%
Orchard Capital Management, LLC 857,138$2,400,0001.02%
Nantahala Capital Management 7,040,487$19,713,0000.61%
OCCUDO QUANTITATIVE STRATEGIES LP 209,040$585,0000.18%
Woodline Partners LP 2,382,522$6,671,0000.18%
RICE HALL JAMES & ASSOCIATES, LLC 1,546,169$4,329,0000.15%
Virtus ETF Advisers LLC 92,771$260,0000.11%
Jump Financial, LLC 155,583$435,0000.07%
GSA CAPITAL PARTNERS LLP 128,626$360,0000.06%
Anson Funds Management LP 95,342$267,0000.05%
View complete list of AKEBIA THERAPEUTICS INC shareholders